Xielan L. Zhao

139 Mid RenMin Road
Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis.

m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis.

Journal: Cancer research communications

Published: July 29, 2025

Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial.

Long-term follow-up of zimberelimab in relapsed or refractory classic Hodgkin lymphoma: Insights from the phase Ⅱ YH-S001-04 clinical trial.

Journal: Leukemia research

Published: August 14, 2024

Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.

Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.

Journal: Lab on a chip

Published: May 15, 2024

Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial.

Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial.

Journal: Annals of hematology

Published: April 29, 2024

Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.

Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Published: May 30, 2023

Factors influencing thrombelastography in pregnancy.

Factors influencing thrombelastography in pregnancy.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: March 31, 2023

Women and girls with haemophilia: A retrospective cohort study in China.

Women and girls with haemophilia: A retrospective cohort study in China.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 29, 2022

LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.

LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.

Journal: Cytokine

Published: July 18, 2022

Efficacy, safety and bioequivalence of the human-derived B-domain-deleted recombinant factor VIII TQG202 for prophylaxis in severe haemophilia A patients.

Efficacy, safety and bioequivalence of the human-derived B-domain-deleted recombinant factor VIII TQG202 for prophylaxis in severe haemophilia A patients.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 22, 2022

Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.

Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 02, 2022

Hemophagocytic lymphohistiocytosis as an onset of diffuse large B-cell lymphoma: A case report.

Hemophagocytic lymphohistiocytosis as an onset of diffuse large B-cell lymphoma: A case report.

Journal: Oncology letters

Published: January 04, 2022

Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study.

Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 29, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026